Healthcare
Monday, July 18, 2016
BRIEF-Teva Pharmaceutical announces pricing of $15 bln of senior notes
* Announces pricing of $15 billion of senior notes in
connection with pending acquisition of Actavis Generics
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment